Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.

@article{Sanoobar2015CoenzymeQS,
  title={Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.},
  author={Meisam Sanoobar and Shahryar Eghtesadi and Amirreza Azimi and Mohammad Khalili and Behnam Khodadadi and S. Vahid Jazayeri and Mahmood Reza Gohari and Nahid Aryaeian},
  journal={Nutritional neuroscience},
  year={2015},
  volume={18 4},
  pages={169-76}
}
OBJECTIVES Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease of central nervous system and recent studies show that inflammatory processes are highly associated with neurodegeneration in the brain. The purpose of this study was to investigate the effect of coenzyme Q10 supplementation on inflammatory and anti-inflammatory markers in patients with MS. METHODS This randomized, double-blind, placebo-controlled clinical study was performed among 48 patients with relapsing… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 9 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis

  • Sanoobar
  • Nutritional Neuroscience 2015 VOL. 18 NO
  • 2015

Is the lipoic acid consumption affect on the cytokine profile in the multiple sclerosis patients: a double blind, placebo, controlled randomized clinical trial

  • M Khalili, V Izadi, S Eghtesadi, A Mirshafiey, MA Sahraian, A Motevalian
  • Neuroimmunomodulation
  • 2013

Similar Papers

Loading similar papers…